Parkside Financial Bank & Trust’s Astria Therapeutics ATXS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-90	Closed	-$1.18K	–	2694
2025 Q4	$1.18K	Hold	90	–	–	﹤0.01%	2284
2025 Q3	$656	Hold	90	–	–	﹤0.01%	2438
2025 Q2	$483	Buy	+90	New	+$436	﹤0.01%	2573

Parkside Financial Bank & Trust's ATXS Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 90 shares — an estimated $1.18K sold.

Parkside Financial Bank & Trust first reported a position in ATXS in Q2 2025 and held it in 3 quarters. The position peaked at $1.18K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Parkside Financial Bank & Trust reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 90 Astria Therapeutics shares in Q1 2026, an estimated $1.18K.
Parkside Financial Bank & Trust first reported a position in Astria Therapeutics in Q2 2025 and held it in 3 quarters.
Parkside Financial Bank & Trust's Astria Therapeutics position peaked at $1.18K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.